Characterization of lymphocyte subsets in patients with common variable immunodeficiency reveals subsets of naive
Marcela Vlková1, Eva Fronková, Veronika Kanderová
1Department of Clinical Immunology and Allergology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic. marcela.vlkova@fnusa.cz
Insights
Common variable immunodeficiency (CVID) involves increased naive B cells, with specific subsets showing abnormal proliferation and developmental pathways. These findings suggest a refined understanding of B cell development in CVID patients.
Area of Science:
- Immunology
- Cell Biology
- Human Genetics
Background:
- Common variable immunodeficiency (CVID) is characterized by impaired B cell immunity.
- Elevated frequencies of naive B cell subsets, specifically CD27(neg)CD21(neg)CD38(neg) B cells, are observed in CVID patients.
- Understanding the phenotype, frequency, and proliferation history of these B cell subsets is crucial for CVID pathogenesis.
Purpose of the Study:
- To investigate the phenotype, frequency, and proliferation history of naive B cell subsets in CVID patients.
- To define distinct subpopulations within the CD27(neg)CD21(neg)CD38(neg) B cell subset and analyze their proliferative capacity.
- To explore the relationship between naive B cell subsets and proposed developmental pathways in CVID.
Main Methods:
- Analysis of B cell subsets from 48 CVID patients and 49 healthy controls using polychromatic flow cytometry.
- Assessment of B cell replication history via PCR-based detection of kappa deletion excision circles (κ-TRECs).
- Stratification of CVID patients into groups with normal (CVID-21norm) or increased (CVID-21lo) CD27(neg)CD21(neg)CD38(neg) B cell proportions.
Main Results:
- Two distinct subpopulations of CD27(neg)CD21(neg)CD38(neg) B cells were identified based on CD24 expression.
- The CD27(neg)CD21(neg)CD38(neg) B cell subset exhibited markedly increased proliferation in CVID-21lo patients, suggesting developmental arrest.
- A significant underrepresentation of the follicular (FO) I subset was observed in CVID-21lo patients, while FO II cells were increased.
- Replication history analysis implied a refined naive B cell developmental scheme where transitional B cells develop into FO II and FO I cells.
Conclusions:
- The CD27(neg)CD21(neg)CD38(neg) B cells increased in CVID patients may originate from FO subsets following CD21 loss.
- Increased proliferation in specific CVID B cell subsets points towards developmental arrest rather than increased bone marrow output.
- These findings contribute to a refined model of human naive B cell development and offer insights into CVID pathophysiology.
Abstract:
Increased proportions of naive B cell subset and B cells defined as CD27(neg)CD21(neg)CD38(neg) are frequently found in patients with common variable immunodeficiency (CVID) syndrome. Current methods of polychromatic flow cytometry and PCR-based detection of κ deletion excision circles allow for fine definitions and replication history mapping of infrequent B cell subsets. We have analyzed B cells from 48 patients with CVID and 49 healthy controls to examine phenotype, frequency, and proliferation history of naive B cell subsets. Consistent with previous studies, we have described two groups of patients with normal (CVID-21norm) or increased (CVID-21lo) proportions of CD27(neg)CD21(neg)CD38(neg) B cells. Upon further analyses, we found two discrete subpopulations of this subset based on the expression of CD24. The B cell subsets showed a markedly increased proliferation in CVID-21lo patients as compared with healthy controls, suggesting developmental arrest rather than increased bone marrow output. Furthermore, when we analyzed CD21(pos) naive B cells, we found two different subpopulations based on IgM and CD24 expression. They correspond to follicular (FO) I and FO II cells previously described in mice. FO I subset is significantly underrepresented in CVID-21lo patients. A comparison of the replication history of naive B cell subsets in CVID patients and healthy controls implies refined naive B cell developmental scheme, in which human transitional B cells develop into FO II and FO I. We propose that the CD27(neg)CD21(neg)CD38(neg) B cells increased in some of the CVID patients originate from the two FO subsets after loss of CD21 expression.
Related Concept Videos
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cells of the Adaptive Immune Response
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...


